Medscape Medical News Neil Osterweil February 18, 2011 (Washington, DC) — The US Department of Health and Human Services has taken the wraps off its 2010 National Vaccine Plan, aimed at improving access to currently available vaccines and spurring development of new ones. The plan’s launch, announced here at a meeting of the National Vaccine […]
Protecting One More Girl
Planned documentary explores the dangers of HPV vaccine Honolulu Weekly by Margot Seeto | Mar 2, 2011 “People don’t just fall over dead.” The One More Girl project / Why would two young men make a documentary about women’s health? For brothers Ryan and David Richardson, who live in Honolulu, the personal became the political. […]
Cervical Cancer vs Prostate Cancer: Is the FDA practicing sexual discrimination?
FDA advisory panels reject the use of two separate prostate cancer prevention measures yet approve cervical cancer preventive shots using virtually the same criteria. What is wrong with this picture? FOR IMMEDIATE RELEASE PRLog (Press Release) – Mar 01, 2011 – November 2010, an FDA advisory panel soundly rejected the proposed use of two drugs, […]
S.A.N.E. Vax, Inc. and Sin Hang Lee, MD offers American consumers reliable HPV genotyping
Natural News Tuesday, March 01, 2011 by: Rosemary Mathis, Director of SANE VAX, INC. S.A.N.E. Vax, Inc. and Dr. Sin Hang Lee, on behalf of Milford Medical Laboratory, have agreed to offer a reliable human papillomavirus (HPV) genotyping test using a PCR system with short target DNA sequencing for safe vaccination practice. Recognizing the alleged […]
SaneVax Analysis of VAERS Reports Post-HPV Vaccination
February 28, 2011
Prepared by the SaneVax Team
SaneVax Analysis of VAERS Reports Post-HPV Vaccination
The SaneVax Team is working to prepare symptom-specific analyses of adverse events experienced after HPV vaccination with Gardasil® and Cervarix®, the currently FDA approved vaccines being marketed as cervical cancer prevention measures. All information in these reports comes directly from VAERS, the vaccine adverse event reporting system in the United States.
SaneVax Inc. is well aware of the limitations to the VAERS system. Not all adverse events are reported. The best estimates to date indicate only 1-10% of adverse events are actually filed in the system. Because VAERS is a voluntary system, and anyone can report an injury, there may be duplicate and/or heresay reports. Nevertheless, the system is the best we have to work with.
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 22
- Next Page »